New HIV/AIDS Clinical Trials Open to Enrollment
New HIV/AIDS trials that are open to participation have been added to www.ClinicalTrials.gov in the last 30 days. Following is a list of those new trials as well as access to the complete clinical trials trials database.
Home
Search
Browse
Resources
Help
What's New
About
1.
Recruiting
Pediatric Nevirapine Resistance Study Conditions: AIDS; HIV Infections
2.
Not yet recruiting
Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 gag DNA Alone or With IL-15 DNA) Given With or Without 3 Different Booster Vaccinations in HIV Uninfected Adults Condition: HIV Infections
3.
Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients with Tuberculosis Conditions: HIV Infections; Tuberculosis
4.
Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals with Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART) Condition: HIV Infections
5.
Modafinil for Fatigue in HIV/AIDS Conditions: HIV Infections; Fatigue; Mental Health
6.
“OK 2004 Study” (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides from Triple-drug Therapy in HIV Subjects Condition: HIV Infection
7.
Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Condition: HIV Infections
8.
Safety and Efficacy of an Antibody to CCR5 in Individuals with HIV who Are Not Currently on Antiretroviral Therapy Condition: HIV Infections
9.
TMC114 with Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients with Limited or no Treatment Options Condition: HIV Infections
10.
Extended Infant Post-exposure Prophylaxis with Antiretrovirals to Reduce Postnatal HIV Transmission Condition: HIV Infections
11.
Study of the 48-Week Virologic and Immunologic Response to Lopinavir/ritonavir (Kaletra) in HIV Positive Adult Patients Condition: HIV Infections
12.
Bangkok Tenofovir Study Condition: HIV Infections
13.
Effectiveness of Nucleoside Supplementation and Substituting Tenofovir Disoproxil Fumarate for Other Drugs in Anti-HIV Regimens in Reversing Fat Loss in HIV Infected Adults Conditions: HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders
14.
The Effect of Low-dose Human Growth Hormone Therapy in HIV Infected Patients Conditions: HIV Infections; Lipodystrophy
15.
Rosuvastatin versus Pravastatin in HIV Patients Treated with Boosted Protease Inhibitors (PI) Conditions: Hyperlipidemia; HIV Infections
16.
Efavirenz or Atazanazir/Ritonavir Given with Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults Condition: HIV Infections
17.
Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Conditions: HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders
18.
Improving HIV Screening by Nurse Rapid Testing, Streamlined Counseling Conditions: Health Care Quality, Access, and Evaluation; Delivery of Health Care; Immune System Disease; HIV Infections
07/18/05
Source
www.clinicaltrials.gov
HIV/AIDS Topics [ A to Z ]
Abacavir Sensitivity Reaction Acquired Drug Resistance Acquired Rectal Fistula Adherence Adolescents African Americans Age/aging AIDS-defining Illnesses AIDS-related Non-Hodgkin's Lymphoma Alcohol Alternative Therapies ALT/AST Anal Intraepithelial Neoplasia (AIN) Anemia / Fatigue Antimycobacterial Prophylaxis Atheroschlerosis Aspergillosis Autoimmune Thyroid Disease Bacteremia Bacterial Infections Bartonella Body Mass Index (BMI) Bone Disorders Boosted Protease Inhibitors Breast-feeding Buffalo Hump (BH) Caesarean section Candidiasis Cancers Cardiovascular Disease CXCR4 Co-receptor CCR5 Co-receptor CD4 T Cell Count/ Percent CD4+ and CD8 in Whole Blood CD8+ T Cell CD8 and CD3 Cells Cerebrospinal Fluid (CSF) Cholesterol / Triglycerides Children and Infants Central Nervous System (CNS) Clinical Trials CMV Retinitis Complementary Alternative Therapies Cosmetic Procedures CYP3A Pathway Cryptococcus Cytomegalovirus Dementia Depression Developing Countries Diabetes Diarrhea / Gastrointestinal Dietary Intake Directly Observed Therapy (DOT) Disease Progression Dosing Drug Abuse Drug Interactions Drug Pricing Drug Resistance Testing Dyslipidemias Elevated bilirubin and Jaundice Elevated Creatinine Level Entry Inhibitors Epstein Barr Virus Epidemiology Eradication (HIV) Ethnicity Experimental Drugs Experimental Vaccine Facial Implants Fat Loss Fat Accumulation Fat Redistribution FDA-Approved Treatments Fixed-dose Combinations (FDC) Flu / Fever Fungal Infections Fusion or Entry Inhibitors GB Virus C (GBC of hepatitis G) Gender Generics Genetics Genotype Resistance Testing Glucose Metabolism / Insulin Resistance Growth Failure Growth Hormone Guidelines Gynecomastia HAART / Mega-HAART Hairy leukoplakia Hepatotoxicity (Liver Toxicity) Hispanic Ethnicity Histoplasmosis HIV Antibody HIV Eradication HIV Prevalence HIV Proviral DNA Testing HIV p24 Antigen HIV-related Adverse Events HIV Replication HIV RNA and HIV bDNA Testing HIV Therapeutics HIV-1 Fitness Assay Hodgkin's Disease Hormone Therapies Hospice Care Human Herpesvirus 8 (HHV-8) Humanpapillomavirus (HPV) Hydroxyurea (HU) Hyperlactatemia Hyperlipidemia Hypersusceptibility Hyperbilirubinemia / Jaundice Hypertension Hypophosphatemia Hypothyroidism Immunotherapy Immune Based Therapy Immunosuppression Immune Restoration Disease Immune Reconstitution Disease (IRD) Immune Reconstitution Inflammatory Syndrome (IRIS) Infants Infective Endocarditis Injection Site Reactions Insulin Resistance Intensification Therapy Injection Drug Users (IDU) Integrase Inhibitors JC Virus Kaposi sarcoma Kidney Toxicity / Failure Kinetic PCR Lactic Acidosis/Hyperlactatemia Liver Enzyme Kaposi's Sarcoma Leukoencephalopathy Lipid Abnormalties Long-term Non Progression Lung Diseases Non-Tuberculosis Lung Diseases Malignancies Mega-HAART Men Who Have Sex with Men (MSM) Meningoencephalitis Microbicides Miscellaneous Mitochondrial Toxicity Mortality and Morbidity Mother-to-Child Transmission Multidrug Resistant (MDR) HIV Mutation Resistance Myalgias (muscle aches) Mycobacterium avium Complex Myelopathy Myocardial Infarction (MI) Natural History NAMs (nucleoside-associated resistance mutations) Nausea Neonatal Transmission Nephrotoxicity Neopterin Neurotoxicity Neutropenia Nevirapine-associated Rash Nitazoxanide Nucleic Acid Screening Test Non-AIDS Related Hodgkin's Lymphoma Non-Tuberculosis Lung Diseases Non-Nucleoside Reverse Transcriptase Inhibitors (nNRTIs) Non-occupational Post Eexposure Prophylaxis (NPEP) NNRTI Toxicities and Side Effects Guide Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Nucleotide Reverse Transcriptase Inhibitors (NtRTIs) Nutrition Opportunistic Infections (OIs) Oral OIs/ hairy leukoplakia/ warts Pain Palliative Care Pancreatitis Parasites Pathogenesis Pediatrics Peripheral Neuropathy Perinatal Transmission Pharmacokinetics Pharmacodynamics Pneumonia Pneumocystis carinii pneumonia (PCP) Phenotype Resistance Testing Pharmacokinetics Progressive Multifocal Leukoencephalopathy (PML) Pheumonia Physical Exercise Positron Emission Topography Protease Assay Proteinuria and Elevated Creatinine Level Psychiatric (mental) PML Post Exposure Prophylaxis (PEP) Post-traumatic Stress Disorder (PTSD) Pregnancy Prevention Primary HIV Infection Protease Inhibitors (PIs) / Boosted PIs Protease Inhibitor Toxicities/Side Effects (PDF) Public Policy Quality of Life Race / Ethnicity real-time DNA PCR (RT DNA-PCR) Renal (Kidney) Toxicity / Failure Replication Capacity Tests Resistance Resistance Mutation Resistance Testing Resistance Training Ritonaivr Boosted PIs Safer Sex Salvage Therapies Seroconversion Severe Adverse Drug Reactions Sexual Dysfunction Sexually Transmitted Diseases Side Effects Simplification Regimens/Trials Skin Conditions Smoking Staphylococcus Aureus Steroids Stroke Substance Abuse Suicidal Ideation Survival Super Infection Sustained Virological Response Syphilis Switch Studies TAMs (thymidine analogue mutations) Tat gene Testosterone thrombosis Therapeutic Drug Monitoring (TDM) Therapeutic HIV Vaccines Thyroid Disease Toxicities and Side Effects Toxicities Guides Toxoplasmosis Transmission Transplantation Treatment Failure Treatment Guidelines Treatment Interruptions (TIs) Tuberculosis Undetectable HIV Viral Load Unsafe Sex Vaccines Vaginal HIV Shedding Vertical Transmission of HIV Viral (HIV) Set Point Viral Load (HIV RNA or HIV bDNA) Viral Load Rebound / Increase Virco Antivirogram Virologic Control Virologic Failure Visceral Adiposity Virtual Phenotype Resistance Testing Wasting - HIV White Race / Caucasian Women
